Why the study?
Myopericarditis and acute myocardial infarction frequently present similarly despite different underlying pathogenesis and treatment, creating a need to improve their differentiation on emergency department presentation.
Does the admission CRP/troponin ratio improve the differentiation between myopericarditis and acute myocardial infarction in patients presenting to the emergency department?
Population
1898 consecutive patients comprising 1025 STEMI, 518 NSTEMI, and 355 myopericarditis patients
Comparison
Admission CRP/troponin ratio across STEMI, NSTEMI, and myopericarditis
Design
Single-center registry diagnostic accuracy study
Authors
Loading...
May aid ED differentiation of myopericarditis from AMI; hypothesis-generating and requires prospective validation before clinical use.
Does the admission CRP/troponin ratio improve the differentiation between myopericarditis and acute myocardial infarction in patients presenting to the emergency department?
An admission CRP/troponin ratio >500 is a highly specific biomarker tool that can help differentiate myopericarditis from acute myocardial infarction, potentially reducing unnecessary invasive evaluations.
Meisel et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: